AMBEV S.A. vs CLOROX CO /DE/. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ABEV and CLX diverge most: on revenue growth, ABEV reads +4.8% and CLX reads -3.8%; on debt / equity, ABEV reads 0.00 and CLX reads 44.33. The rest of the comparable metrics sit closer together. What ABEV's price implies is a bet that sits within the historical range (whole-company basis). What CLX's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | ABEV | CLX |
|---|---|---|
| Price | $3.07 | $96.45 |
| Market cap | $47.9B | $11.7B |
| Sector | Food & Beverage | Household Products |
| Stage | Mature | Mature |
| P/E | — | 15.7 |
| P/B | — | 127.68 |
| P/S | — | 1.74 |
| EV/EBITDA | — | 64.8 |
| Revenue growth | +4.8% | -3.8% |
| Gross margin | 34.5% | 43.2% |
| Operating margin | 17.8% | — |
| Net margin | 12.2% | 11.2% |
| Return on equity | 18.0% | 821.7% |
| Return on assets | 11.0% | 11.8% |
| Return on invested capital | 20.8% | — |
| FCF yield | — | 3.2% |
| Dividend yield | — | 5.1% |
| Debt / equity | 0.00 | 44.33 |
| Current ratio | 0.96 | 0.84 |
| Altman Z (solvency) | 4.03 | 2.12 |
| Piotroski F (quality) | 8 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.